Evidence map›Paper›PMID 26116159›Full record

Trial reportUltrasound in medicine & biology2015

Ultrasound imaging of breast tumor perfusion and neovascular morphology.

Kenneth Hoyt, Heidi Umphrey, Mark Lockhart, Michelle Robbin, Andres Forero-Torres

Abstract readClinical Trial
In one paragraph

Trial report in Ultrasound in medicine & biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Super-Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. 3D Harmonic and Subharmonic Imaging for Characterizing Breast Lesions: A Multi-Center Clinical Trial.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2022
    Article
  12. Article
  13. 3-D Super-Resolution Ultrasound Imaging for Monitoring Early Changes in Breast Cancer after Treatment with a Vascular-Disrupting Agent.IEEE International Ultrasonics Symposium : [proceedings]. IEEE International Ultrasonics Symposium · 2021
    Article
  14. Article
  15. Article
  16. Three-dimensional evaluation of microvascular networks using contrast-enhanced ultrasound and microbubble tracking.IEEE International Ultrasonics Symposium : [proceedings]. IEEE International Ultrasonics Symposium · 2020
    Article
  17. Deep Learning of Spatiotemporal Filtering for Fast Super-Resolution Ultrasound Imaging.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2020
    Article
  18. Article
  19. Three-dimensional super-resolution ultrasound imaging of chicken embryos - A validation framework for analysis of microvascular morphology.IEEE International Ultrasonics Symposium : [proceedings]. IEEE International Ultrasonics Symposium · 2020
    Article
  20. Faster motion correction of clinical contrast-enhanced ultrasound imaging using deep learning.IEEE International Ultrasonics Symposium : [proceedings]. IEEE International Ultrasonics Symposium · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenneth HoytDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: hoyt@uab.edu.
Heidi UmphreyDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Mark LockhartDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Michelle RobbinDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Andres Forero-TorresDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Rexinoids for Breast Cancer PreventionP50CA089019 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLAND, KIRBY I. · 2000 to 2011
$26.0M
Molecular Ultrasound Imaging of Cancer Response to Antiangiogenic TherapyK25EB017222 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2014 to 2018
$804k
NCI NIH HHS P30 CA013148NCI NIH HHS P50 CA089019NCI NIH HHS P50 CA89019NIBIB NIH HHS K25 EB017222
6 · The paper itself

Abstract

A novel image processing strategy is detailed for simultaneous measurement of tumor perfusion and neovascular morphology parameters from a sequence of dynamic contrast-enhanced ultrasound (DCE-US) images. After normalization and tumor segmentation, a global time-intensity curve describing contrast agent flow was analyzed to derive surrogate measures of tumor perfusion (i.e., peak intensity, time-to-peak intensity, area under the curve, wash-in rate, wash-out rate). A maximum intensity image was generated from these same segmented image sequences, and each vascular component was skeletonized via a thinning algorithm. This skeletonized data set and collection of vessel segments were then investigated to extract parameters related to the neovascular network and physical architecture (i.e., vessel-to-tissue ratio, number of bifurcations, vessel count, average vessel length and tortuosity). An efficient computation of local perfusion parameters was also introduced and operated by averaging time-intensity curve data over each individual neovascular segment. Each skeletonized neovascular segment was then color-coded by these local measures to produce a parametric map detailing spatial properties of tumor perfusion. Longitudinal DCE-US image data sets were collected in six patients diagnosed with invasive breast cancer using a Philips iU22 ultrasound system equipped with a L9-3 transducer and Definity contrast agent. Patients were imaged using US before and after contrast agent dosing at baseline and again at weeks 6, 12, 18 and 24 after treatment started. Preliminary clinical results suggested that breast tumor response to neoadjuvant chemotherapy may be associated with temporal and spatial changes in DCE-US-derived parametric measures of tumor perfusion. Moreover, changes in neovascular morphology parametric measures may also help identify any breast tumor response (or lack thereof) to systemic treatment. Breast cancer management from early detection to therapeutic monitoring is currently undergoing profound changes. Novel imaging techniques that are sensitive to the unique biological conditions of each individual tumor represent valuable tools in the pursuit of personalized medicine.

Indexed as

Blood Flow VelocityAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsFemaleHumansImage Interpretation, Computer-AssistedMiddle AgedNeovascularization, PathologicPerfusion ImagingReproducibility of ResultsSensitivity and SpecificityTreatment OutcomeUltrasonography, MammaryAngiogenesisBreast cancerContrast agentMicrobubblesNeovascular morphologyTumor perfusionUltrasound

Identifiers

PMID26116159
PMCPMC4526459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.